Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) is a Healthcare company (Medical - Instruments & Supplies) with a market capitalization of $1.7B. The Maz Rating grades it against the other companies in its sector.
Kestra Medical Technologies, Ltd.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $28.27, Kestra Medical Technologies, Ltd. trades at 15.8x sales and 7.4x book value. Over the last twelve months it generated about $107M of revenue and a net loss of $159M. It runs a gross margin of 53.9%, an operating margin of -134.5% and a net margin of -140.4%. It shows return on equity of -64.2%, return on invested capital of -48.0% and a free cash flow yield of -7.3%. On the balance sheet: a debt-to-equity ratio of 0.34 and a current ratio of 4.69. Over the past 52 weeks the share price ranged from $17.34 to $31.99, with a beta of 0.62.
Kestra Medical Technologies, Ltd. does not currently pay a dividend.
4 Wall Street analyst ratings cover the stock: 3 Buy and 1 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.